‘India should show leadership in TB research’
With a $9.1 million funding in 2014 by several Indian government agencies, India is ranked fifth in the world with
Read MoreWith a $9.1 million funding in 2014 by several Indian government agencies, India is ranked fifth in the world with
Read More“TB is the leading infectious killer, yet countries still follow old and dangerous [TB diagnostic and treatment] polices,” MSF Access
Read MoreTreating young children afflicted with drug-sensitive TB disease will no longer be the same. After years of neglect, the availability
Read MoreFor the first time, child-friendly TB drugs for first-line medication in a fixed-dose combination was launched by TB Alliance, UNITAID
Read MoreThanks to the Zero TB Cities project, if everything works to plan, Chennai may drastically reduce TB mortality, shrink the
Read MoreUnlike people with drug-susceptible TB, those with multi drug-resistant TB (MDR-TB) are less likely to transmit disease to others living
Read MoreFor the first time in India, the superiority of Xpert MTB/RIF over smear microscopy for bacteriological confirmation of pulmonary TB
Read MoreThe Joint Monitoring Mission 2015 has come down heavily on the Revised National Tuberculosis Control Programme (RNTCP) and the
Read MoreThree major global research centres in India will receive funding coming out of collaboration between the UK Medical Research Council
Read MoreA proof-of-concept study has successfully identified two small molecules (imipramine and norclomipramine) that can arrest the growth of TB bacteria
Read MoreThanks to metformin, a drug that is commonly prescribed for type 2 diabetes patients, treating TB — both the drug-sensitive
Read MoreIndia has the highest number of people in the world with active tuberculosis. The incidence of TB is 2.2
Read MoreThe global burden and mortality from HIV/AIDS, TB and malaria across the world, and in the developing countries in particular,
Read More